Jiangsu, China

Yu He

This inventor holds 1 USPTO granted patent. Top assignee: China Pharmaceutical University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu He. Retrieved from https://idiyas.com/inventor/yu-he-di6jw90o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yu He in Immunology

Introduction

Yu He is an accomplished inventor based in Jiangsu, China. He has made significant contributions to the field of immunology through his innovative research and development of new peptides. His work focuses on enhancing the immunogenicity of antigens, which is crucial for vaccine development.

Latest Patents

Yu He holds a patent for a helper epitope peptide and its applications. The patent describes a helper epitope peptide obtained by replacing one or two amino acid residues in the helper T cell epitope PADRE with 4-nitrophenylalanine. This innovative peptide is effective in enhancing the immunogenicity of an antigen or antigenic epitope, and it can be used for preparing or constructing vaccines. He has 1 patent to his name.

Career Highlights

Yu He is affiliated with China Pharmaceutical University, where he conducts his research. His work has garnered attention for its potential applications in vaccine development and immunotherapy. His contributions are paving the way for advancements in the field of immunology.

Collaborations

Yu He collaborates with notable colleagues, including Wenbing Yao and Hong Tian. Their combined expertise enhances the research output and innovation in their projects.

Conclusion

Yu He's innovative work in developing helper epitope peptides represents a significant advancement in immunology. His contributions are vital for the future of vaccine development and immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…